Journal Information
Original Article
Full text access
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement
Diferencia sex-específica para el cáncer de pulmón de células pequeñas del avance de la inmunoterapia
You Moa,b, Yiwei Qinc, Jian Shangguanb, Duncan Weia, Meng Wub, Dawei Chenb,1,
Corresponding author
dave0505@yeah.net

Corresponding author.
, Jinming Yua,b,1,
Corresponding author
sdyujinming@163.com

Corresponding author.
a Laboratory of Molecular Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
b Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
c Cheeloo College of Medicine, Shandong University
Highlights

  • Provided the first evidence of a significant difference in immunotherapy advance among sex for SCLC based population mortality. Patient with SCLC in women benefit significantly.

Article

This article is available in English

Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement

You Mo, Yiwei Qin, Jian Shangguan, Duncan Wei, Meng Wu, Dawei Chen, Jinming Yu
10.1016/j.arbres.2024.05.025
Arch Bronconeumol. 2024;60 Supl 2:S13-S21
Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?